Johnson and Johnson (Tibotec BVBA)

Johnson and Johnson (Tibotec BVBA)

Name of leader and affiliation
Koen Andries, VP Scientific Fellow, Janssen Infectious Diseases – Diagnostics BVBA (Johnson and Johnson)

Janssen Infectious Diseases – Diagnostics BVBA is dedicated to advancing the treatment of HIV/AIDS, hepatitis C, tuberculosis and other infectious diseases. Our mission is to be a world leader in the discovery and development of unique and innovative anti-infectives for diseases of high unmet medical need.”

Sorry, no posts found for this author.

Consortium Partners

PreDiCT-TB brings together twenty-one leading European research partners in tuberculosis from both Industry and Academia

View More

The research leading to these results has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement n° 115337, resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies’ in kind contribution.

The communication contained within this site reflects the author’s view and neither IMI nor the European Union and EFPIA are liable for any use that may be made of the information contained therein.